OSCR

Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases.

Overview

Authors: Ajay Konuri1,2,3, Gonzalo Castro Leal4,5, Niloufar Zebarjadi6, Annegret Habich6, Nicolás Castellanos-Perilla6,7,8, María Camila Gonzalez8, John-Paul Taylor9, Michael Firbank9, Daniel Alcolea10,11, Alexandre Bejanin10,11, Kurt Segers12, Florence Benoit12, Ahmet Turan Isik13, Bedia Samanci14, Consuelo Cháfer-Pericás15, Richard Wade-Martins16, Michele T.M. Hu16, Rohan Bhome4,17, Ivelina Dobreva17, Zuzana Walker18,19
and 10 other authorsDag Aarsland9,20, Eric Westman6,21, Daniel Ferreira6,22, Glenda Halliday2,23, Simon J.G. Lewis3, Rimona S. Weil18,24, Ramon Landin-Romero2,25, Christian Lambert26, Neil P. Oxtoby4,5, Elie Matar1,2,27
27 affiliations
  1. Central Clinical School, Faculty of Medicine and Health, University of Sydney, Australia
  2. Brain and Mind Centre, Faculty of Medicine and Health, University of Sydney, Australia
  3. Parkinson's Disease Research Centre, Macquarie Medical School, Macquarie University, Australia
  4. UCL Hawkes Institute, University College London, 90 High Holborn, London WC1V 6LJ, UK
  5. UCL Department of Computer Science, University College London, 66–72 Gower Street, London WC1E 6EA, UK
  6. Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society (NVS), Center for Alzheimer Research, Karolinska Institutet, Blickagången 16, Huddinge, Stockholm 141 52, Sweden
  7. Department of Clinical Medicine, University of Bergen, Postboks 7804, Bergen 5020, Norway
  8. Centre for Age-Related Medicine (SESAM), Stavanger University Hospital, Postboks 8100, Stavanger 4068, Norway
  9. Translational and Clinical Research Institute, Campus for Ageing and Vitality, Newcastle Upon Tyne NE4 5PL, UK
  10. Sant Pau Memory Unit, IR SANT PAU, Hospital de la Santa Creu i Sant Pau, 167 Sant Antoni Maria Clare, Barcelona 08025, Spain
  11. Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 5 Valderrebollo Street, Madrid 28031, Spain
  12. Neurology and Geriatrics Department, Brugmann University Hospital, Université Libre De Bruxelles, Place Arthur Van Gehuchten 4, Brussels 1020, Belgium
  13. Unit for Brain Aging and Dementia, Department of Geriatric Medicine, Dokuz Eylul University, School of Medicine, Balcova, Izmir 35340, Turkey
  14. Behavioral Neurology and Movement Disorders Unit, Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Topkapı, Turgut Özal Millet Cd, Istanbul 34093, Turkey
  15. Instituto de Investigación Sanitaria La Fe, Avenida Fernando Abril Martorell, 106, Valencia 46026, Spain
  16. Oxford Parkinson's Disease Centre, University of Oxford, Oxford, UK
  17. Dementia Research Centre, University College London, 8–11 Queen Square, London WC1N 3AR, UK
  18. Division of Psychiatry, University College London, 6th Floor, Wings A and B, Maple House, 149 Tottenham Ct Rd, London W1T 7NF, UK
  19. Essex Partnership University NHS Foundation Trust, Sankey House, 81 High Rd, Pitsea, Basildon SS13 3BB, UK
  20. Centre for Healthy Brain Ageing, Institute of Psychiatry, Psychology, and Neuroscience, King’s College London, 16 De Crespigny Park, London SE5 8AB, UK
  21. The Ageing Epidemiology Research Unit, School of Public Health, Imperial College London, White City Campus, 90 Wood Lane, London W12 0BZ, UK
  22. Facultad de Ciencias de La Salud, Universidad Fernando Pessoa Canarias, Calle Alcalde Francisco Hernández González, 28, Las Palmas 35001, Spain
  23. School of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Australia
  24. National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London WC1N 3BG, UK
  25. School of Health Sciences, Faculty of Medicine and Health, University of Sydney, Australia
  26. Functional Imaging Laboratory, Department of Imaging Neuroscience, Institute of Neurology, University College London, 12 Queen Square, London WC1N 3AR, UK
  27. Department of Neurology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
Journal: EBioMedicine, volume 131, article 106400
Dates: received 16 February 2026; accepted 6 July 2026; published online 5 August 2026; in print September 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1016/j.ebiom.2026.106400 · PMID 42556137 · PMCID PMC13471053 · OpenAlex W7172524609
Open access: gold, a free copy (OpenAlex)
Status: code verified (how the code is found and verified)
Categories: structural MRI / diffusion (modality), human (organism), Alzheimer's / dementia (population), Parkinson's (population), clinical / translational (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning, Preprocessing, fMRI & imaging
Keywords: Dementia, Heterogeneity, Lewy body diseases, Subtypes, Neurodegeneration, Machine learning
MeSH: Lewy Body Disease*, Aged, Atrophy, Brain, Disease Progression, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Parkinson Disease (* major topic)
Topic: Parkinson's Disease Mechanisms and Treatments (Clinical Neurology, Medicine), according to OpenAlex
Funding: Australian Rotary Health; Rotary Club of Belconnen (SC4968); UKRI | Medical Research Council (MR/S03546X/1, MR/X024288/1); Department of Health | National Health and Medical Research Council (NHMRC) (2008565, 2034292, GNT2010064); University of Sydney Institute for Infectious Diseases; Monument Trust Discovery (J-1403); National Institute for Health Research; Oxford University Hospitals National Health Service Trust; University of Oxford; Newcastle Biomedical Research Centre; Wellcome Career Development Award (#225263/Z/22/Z); Rosetrees Trust; Parkinson's UK; Lewy Body Society; Michael J. Fox Foundation for Parkinson’s Research; University College London Hospitals Biomedical Research Centre; Wolfson Foundation; Eisai; Medical Research Council (MR/R006504/1); Hilary-Galen Weston Foundation; Instituto de Salud Carlos III (PI18/00435, PI22/00611, INT19/00016, INT23/00048, PI25/00422); Department of Health Generalitat de Catalunya PERIS programme (SLT006/17/125, SLT042/25/000034); ARUK; Wellcome Trust (227341/Z/23/Z); NACC; NIA; NIH (U24 AG072122); ADRCs (P30 AG062429, P30 AG066468, P30 AG062421, P30 AG066509, P30 AG066514, P30 AG066530, P30 AG066507, P30 AG066444, P30 AG066518, P30 AG066512, P30 AG066462, P30 AG072979, P30 AG072972, P30 AG072976, P30 AG072975, P30 AG072978, P30 AG072977, P30 AG066519, P30 AG062677, P30 AG079280, P30 AG062422, P30 AG066511, P30 AG072946, P30 AG062715, P30 AG072973, P30 AG066506, P30 AG066508, P30 AG066515, P30 AG072947, P30 AG072931, P30 AG066546, P30 AG086401, P30 AG086404, P30 AG086403, P30 AG072958, P30 AG072959, P30 AG092752); SCAN; U24 grant (AG067418); national institute on aging; Arizona Alzheimer’s Center (P30 AG072980, R01 AG069453, P30 AG019610); State of Arizona; BU (P30 AG013846); Cleveland ADRC (P30 AG062428); Cleveland Clinic (P20AG068053, P50 AG008702); Duke University; UNC; ADRC (P30 AG072958); Emory University (P30AG066511); Indiana University (R01 AG19771, P30 AG10133, P30 AG072976, R01 AG061788, R01 AG053993, U01 AG057195, U19 AG063911); Indiana University Department of Radiology and Imaging Sciences; Johns Hopkins University (P30 AG066507); Mayo Clinic (P50 AG016574); Mount Sinai (P30 AG066514, R01 AG054110, R01 AG053509); New York University (P30AG066512-01S2, R01AG056031, R01AG056531); Northwestern University (P30 AG013854, R01 AG045571, R56 AG045571, R01 AG067781, U19 AG073153, R01 DC008552, R01 AG077444, R01 NS075075, R01 AG056258); Oregon Health & Science University (P30 AG066518, R56 AG074321); Rush University (P30 AG010161); Stanford University (66515, P50 AG047366); University of Alabama; University of California, Davis (P30 AG10129, P30 AG072972); University of California, Irvine (P50 AG016573); UC San Diego (P30AG062429); University of California, San Francisco (P30 AG062422); University of Kansas (P30 AG035982); University of Kentucky (UK) (P30 AG028283-15S1); University of Michigan ADRC (P30AG053760, P30AG072931); Cure Alzheimer's Fund (200775, U19 NS120384); University of Michigan (R01 AG068338, S10OD026738-01, R01 AG058724, R35 AG072262, W81XWH2110743, R01 AG073235, 1I01RX001534, IRX001381); University of New Mexico (P20 AG068077); Penn Medicine, University of Pennsylvania (2019NF4100087335); Rooney Family Research (R01 AG055005); University of Pittsburgh (P50 AG005133); University of Southern California (P50 AG005142); University of Washington (P50 AG005136); University of Wisconsin-Madison (P50 AG033514); Vanderbilt University (P20 AG068082); Wake Forest (P30AG072947); Washington University (P01 AG03991, P01 AG026276, P20 MH071616, P30 AG066444, P30 NS098577, R01 AG021910, R01 AG043434, R01 EB009352, UL1 TR000448, U24 RR021382); Avid Radiopharmaceuticals; Eli Lilly (P50 AG047270, R01AG052560, R01AG062276, P30AG066506-03, P50 AG047266); Parkinson’s Research and funding partners; AbbVie; Alamar Biosciences; Aligning Science Across Parkinson’s; Arrowhead Pharma; Arvinas; AskBio; BIAL; BioArctic; Biohaven; BlueRock Therapeutics; Bristol-Myers Squibb; Calico Labs; Capsida Biotherapeutics; Critical Path Institute; DaCapo Brainscience; Denali; Edmond J. Safra Foundation; Gain Therapeutics; GE Healthcare; Genentech; GSK; Insitro; Janssen; Lundbeck; Merck & Co., Inc; Neumora; Neuron23; Novartis; Olink; Regeneron; F. Hoffmann-La Roche Ltd; Sanofi; Tenvie; UCB; Vanqua Bio; Voyager Therapeutics; Weston Family Foundation
Citations: not cited yet (Europe PMC); 79 references in the paper
Research resources: RRID:SCR_006431

Abstract

Background: Lewy body diseases (LBD) collectively share α-synuclein Lewy pathology, yet present wide clinical heterogeneity, with overlapping motor and non-motor features and progression patterns that challenge traditional diagnostic boundaries.

Methods: To resolve this spatiotemporal heterogeneity at the biological level, we applied a data-driven atrophy progression framework to MRI data from 833 individuals across Parkinson’s disease, dementia with Lewy bodies, and prodromal isolated REM sleep behaviour disorder using the Subtype and Stage Inference algorithm.

Findings: Four transdiagnostic subtypes (A: Early cortico-limbic/late basal ganglia, B: Early basal ganglia/late limbic, C: Early temporo-limbic/late basal ganglia, and D: Early basal ganglia–cingulate/late cortex) emerged, each defined by a distinct spatiotemporal progression of atrophy that explained cognitive, motor, and psychiatric variability. An early cortico-limbic/late basal ganglia subtype represented a dementia-prone subtype across clinical diagnoses, with limbic involvement associating with the emergence of visual hallucinations.

Interpretation: These biologically relevant spatiotemporal atrophy subtypes provide an interpretable stratification of patients with LBD, with the potential to refine prognosis, improve clinical trial stratification, and guide precision therapeutic approaches.

Funding: This work was made possible by an Ignition grant from the 10.13039/501100001774University of Sydney and 10.13039/501100000765University College London (Global Engagement Fund).

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

No file of the authors' code could be read here: it is described below, and read at its source.

ucl-usyd-transcend.github.io

License: none: the authors keep all their rights
State: the link answers, verified on 27 September 2026
Evidence: the link answers
Software Heritage: not checked
Found in: the text, “Ethics approval and consent to participate”
Not found: README, license file, CITATION.cff, environment file, tests, continuous integration, documentation
Availability: 1 check, the latest on 27 September 2026: the link answers (HTTP 200)
  • 27 September 2026: the link answers (HTTP 200)

The paper's code and data availability statement is in the Data section.

Tracing map

Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.

What the map holds:

  • 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
  • 0 scripts, each with its path and the digest of its content;
  • no match between paragraphs and code yet;
  • neither the text of the paper nor the code itself.

Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.

Data

No dataset and no data link were found in the paper.

Data sharing statement

Data supporting the findings of this study are available from the corresponding authors, upon reasonable request. The pySuStaIn algorithm can be publicly accessed at https://github.com/ucl-pond/pySuStaIn.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 3, 28 September 2026

  • Authors: added Gonzalo Castro Leal (0000-0002-5496-971X); Ahmet Turan Isik (0000-0001-5867-6503); Eric Westman (0000-0002-3115-2977); Neil P. Oxtoby (0000-0003-0203-3909); removed Gonzalo Castro Leal; Ahmet Turan Isik; Eric Westman; Neil P. Oxtoby

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 30 authors, 6 keywords, 11 MeSH terms, 110 funders, 79 references, 1 RRID.

Cite

This paper

Konuri, A., Leal, G. C., Zebarjadi, N., Habich, A., Castellanos-Perilla, N., Gonzalez, M. C., Taylor, J.-P., Firbank, M., Alcolea, D., Bejanin, A., Segers, K., Benoit, F., Isik, A. T., Samanci, B., Cháfer-Pericás, C., Wade-Martins, R., Hu, M. T., Bhome, R., Dobreva, I., . . . Matar, E. (2026). Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases. EBioMedicine, 131, 106400. https://doi.org/10.1016/j.ebiom.2026.106400

BibTeX

@article{konuri2026data,
author = {Konuri, Ajay and Leal, Gonzalo Castro and Zebarjadi, Niloufar and Habich, Annegret and Castellanos-Perilla, Nicolás and Gonzalez, María Camila and Taylor, John-Paul and Firbank, Michael and Alcolea, Daniel and Bejanin, Alexandre and Segers, Kurt and Benoit, Florence and Isik, Ahmet Turan and Samanci, Bedia and Cháfer-Pericás, Consuelo and Wade-Martins, Richard and Hu, Michele T.M. and Bhome, Rohan and Dobreva, Ivelina and Walker, Zuzana and Aarsland, Dag and Westman, Eric and Ferreira, Daniel and Halliday, Glenda and Lewis, Simon J.G. and Weil, Rimona S. and Landin-Romero, Ramon and Lambert, Christian and Oxtoby, Neil P. and Matar, Elie},
title = {{Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases}},
journal = {EBioMedicine},
year = {2026},
month = aug,
volume = {131},
pages = {106400},
publisher = {Elsevier},
issn = {2352-3964},
doi = {10.1016/j.ebiom.2026.106400},
url = {https://doi.org/10.1016/j.ebiom.2026.106400},
pmid = {42556137},
pmcid = {PMC13471053}
}

RIS

TY - JOUR
AU - Konuri, Ajay
AU - Leal, Gonzalo Castro
AU - Zebarjadi, Niloufar
AU - Habich, Annegret
AU - Castellanos-Perilla, Nicolás
AU - Gonzalez, María Camila
AU - Taylor, John-Paul
AU - Firbank, Michael
AU - Alcolea, Daniel
AU - Bejanin, Alexandre
AU - Segers, Kurt
AU - Benoit, Florence
AU - Isik, Ahmet Turan
AU - Samanci, Bedia
AU - Cháfer-Pericás, Consuelo
AU - Wade-Martins, Richard
AU - Hu, Michele T.M.
AU - Bhome, Rohan
AU - Dobreva, Ivelina
AU - Walker, Zuzana
AU - Aarsland, Dag
AU - Westman, Eric
AU - Ferreira, Daniel
AU - Halliday, Glenda
AU - Lewis, Simon J.G.
AU - Weil, Rimona S.
AU - Landin-Romero, Ramon
AU - Lambert, Christian
AU - Oxtoby, Neil P.
AU - Matar, Elie
TI - Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases
T2 - EBioMedicine
J2 - EBioMedicine
PY - 2026
DA - 2026/08/05
VL - 131
SP - 106400
SN - 2352-3964
PB - Elsevier
DO - 10.1016/j.ebiom.2026.106400
UR - https://doi.org/10.1016/j.ebiom.2026.106400
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.ebiom.2026.106400",
"type": "article-journal",
"title": "Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases",
"container-title": "EBioMedicine",
"author": [
{
"family": "Konuri",
"given": "Ajay"
},
{
"family": "Leal",
"given": "Gonzalo Castro"
},
{
"family": "Zebarjadi",
"given": "Niloufar"
},
{
"family": "Habich",
"given": "Annegret"
},
{
"family": "Castellanos-Perilla",
"given": "Nicolás"
},
{
"family": "Gonzalez",
"given": "María Camila"
},
{
"family": "Taylor",
"given": "John-Paul"
},
{
"family": "Firbank",
"given": "Michael"
},
{
"family": "Alcolea",
"given": "Daniel"
},
{
"family": "Bejanin",
"given": "Alexandre"
},
{
"family": "Segers",
"given": "Kurt"
},
{
"family": "Benoit",
"given": "Florence"
},
{
"family": "Isik",
"given": "Ahmet Turan"
},
{
"family": "Samanci",
"given": "Bedia"
},
{
"family": "Cháfer-Pericás",
"given": "Consuelo"
},
{
"family": "Wade-Martins",
"given": "Richard"
},
{
"family": "Hu",
"given": "Michele T.M."
},
{
"family": "Bhome",
"given": "Rohan"
},
{
"family": "Dobreva",
"given": "Ivelina"
},
{
"family": "Walker",
"given": "Zuzana"
},
{
"family": "Aarsland",
"given": "Dag"
},
{
"family": "Westman",
"given": "Eric"
},
{
"family": "Ferreira",
"given": "Daniel"
},
{
"family": "Halliday",
"given": "Glenda"
},
{
"family": "Lewis",
"given": "Simon J.G."
},
{
"family": "Weil",
"given": "Rimona S."
},
{
"family": "Landin-Romero",
"given": "Ramon"
},
{
"family": "Lambert",
"given": "Christian"
},
{
"family": "Oxtoby",
"given": "Neil P."
},
{
"family": "Matar",
"given": "Elie"
}
],
"container-title-short": "EBioMedicine",
"volume": "131",
"page": "106400",
"DOI": "10.1016/j.ebiom.2026.106400",
"PMID": "42556137",
"PMCID": "PMC13471053",
"ISSN": "2352-3964",
"publisher": "Elsevier",
"URL": "https://doi.org/10.1016/j.ebiom.2026.106400",
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
5
]
]
}
}

The tracing map gets a citation of its own once an author has validated it and it has a DOI.

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1101/2025.10.03.25337171 [code]
Transdiagnostic quantitative assessment of dementias using in vivo MRI and data-driven disease progression modelling: a case study in Alzheimer’s disease and dementia with Lewy bodies
Journal: medRxiv (preprint)
In common: Alzheimer's / dementia, structural MRI / diffusion, clinical / translational, 6 references, 3 authors
[2] doi:10.1002/mds.70025 [code]
Functional Magnetic Resonance Imaging (fMRI) Signatures of Progression and Phenoconversion in Prodromal Synucleinopathies.
Journal: Movement disorders : official journal of the Movement Disorder Society
In common: Parkinson's, Alzheimer's / dementia, clinical / translational, 5 references, 2 authors
[3] doi:10.1093/braincomms/fcaf146 [code]
Neuroimaging-based data-driven subtypes of spatiotemporal atrophy due to Parkinson's disease.
Journal: Brain communications
In common: Parkinson's, structural MRI / diffusion, 9 references, author Neil P. Oxtoby
[4] doi:10.1016/j.ebiom.2025.105753 [code]
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorder.
Journal: EBioMedicine
In common: Parkinson's, Alzheimer's / dementia, structural MRI / diffusion, 1 other category, 8 references, author Simon J.G. Lewis
[5] doi:10.1093/braincomms/fcaf173
Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum.
Journal: Brain communications
In common: Alzheimer's / dementia, structural MRI / diffusion, 2 references, 2 authors
[6] doi:10.1038/s41531-025-01037-5
Clinical correlates of data-driven subtypes of deep gray matter atrophy and dopamine availability in early Parkinson's disease.
Journal: NPJ Parkinson's disease
In common: Parkinson's, structural MRI / diffusion, clinical / translational, 8 references
[7] doi:10.1038/s41531-022-00279-x [code]
Dynamic network impairments underlie cognitive fluctuations in Lewy body dementia.
Journal: NPJ Parkinson's disease
In common: Parkinson's, Alzheimer's / dementia, clinical / translational, 1 reference, 2 authors
[8] doi:10.1038/s41593-025-01910-9 [code]
Sympathetic and parasympathetic subtypes of body-first Lewy body disease observed in postmortem tissue from prediagnostic individuals.
Journal: Nature neuroscience
In common: Parkinson's, Alzheimer's / dementia, 8 references
[9] doi:10.1093/brain/awad044 [code]
Mitochondrial function-associated genes underlie cortical atrophy in prodromal synucleinopathies.
Journal: Brain : a journal of neurology
In common: Parkinson's, Alzheimer's / dementia, structural MRI / diffusion, 4 references, author Simon J.G. Lewis
[10] doi:10.1038/s41467-024-49402-x [code]
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.
Journal: Nature communications
In common: Parkinson's, Alzheimer's / dementia, 8 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Add the badge to the code's README

OSCR: the badge of this paper

If you are an author or a maintainer of this paper's code, you can add this badge. It says what OSCR knows of the paper (its code, its validated tracing map) and links the code to this page. Paste one of these snippets under the README's title. Keep the two marks around it, so that the badge can be replaced in place and is never added twice. OSCR changes nothing in your repository.

Markdown
<!-- oscr-badge:start -->
[![OSCR](https://openscicode.org/badge/doi/10.1016/j.ebiom.2026.106400.svg)](https://openscicode.org/badge/doi/10.1016/j.ebiom.2026.106400)
<!-- oscr-badge:end -->
reStructuredText
.. oscr-badge:start

.. image:: https://openscicode.org/badge/doi/10.1016/j.ebiom.2026.106400.svg
   :target: https://openscicode.org/badge/doi/10.1016/j.ebiom.2026.106400
   :alt: OSCR

.. oscr-badge:end
HTML
<!-- oscr-badge:start -->
<a href="https://openscicode.org/badge/doi/10.1016/j.ebiom.2026.106400"><img src="https://openscicode.org/badge/doi/10.1016/j.ebiom.2026.106400.svg" alt="OSCR"></a>
<!-- oscr-badge:end -->

If you choose to, you can have the badge kept up to date for you, with oscr badge --write from the command line or with the GitHub Action in your repository's workflows. Every other form and option (a card, AsciiDoc, LaTeX, shields.io) is on the badge page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Report a mismatch between the code and the paper · Report a code error (signed in)

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Report a reproduction failure (signed in)

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.